WuXi AppTec stock, healthcare

WuXi AppTec stock earns EcoVadis Gold for a third year

Published on 10/08/2026 at 09:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

WuXi AppTec received EcoVadis Gold on October 7, 2026, ranking in the global top 5 percent. H1 revenue rose 38.93 percent to RMB 28.897 billion.

WuXi AppTec stock,  healthcare,  CRDMO,  EcoVadis Gold Medal,  Shanghai Stock Exchange, Illustration mit AI erstellt.
WuXi AppTec stock, healthcare, CRDMO, EcoVadis Gold Medal, Shanghai Stock Exchange, Illustration mit AI erstellt.

WuXi AppTec received the EcoVadis Gold Medal for the third consecutive year on October 7, 2026, while first-half revenue rose 38.93 percent year over year to RMB 28.897 billion. The combination gives investors two distinct signals: a fresh sustainability milestone and continued operating growth in the company's core CRDMO business.

Gold medal reaches top 5 percent

According to BioSpace on October 7, 2026, WuXi AppTec earned the Gold distinction for the third year in a row. EcoVadis reserves the medal for companies ranked in the top 5 percent globally after assessment across environmental, labor and human rights, ethics, and sustainable procurement criteria.

The award does not change the income statement, but it adds a measurable external benchmark to WuXi AppTec's global partner proposition. The company's investor-relations materials describe an integrated research, development, and manufacturing platform operating across more than 30 countries, linking laboratory work with commercial production.

Revenue growth sets the operating tone

In a review of the first-half 2026 interim report, Futunn reported revenue of RMB 28.897 billion, up 38.93 percent from the first half of 2025. Net profit attributable to shareholders reached RMB 11.080 billion, an increase of 29.43 percent, while adjusted non-GAAP net profit reached RMB 10.572 billion, up 89.39 percent.

The same report put continuing-operations backlog at RMB 66.43 billion as of June 30, 2026, up 25.2 percent year over year. WuXi AppTec also lifted full-year 2026 revenue guidance to RMB 58.5 billion to RMB 60.5 billion from RMB 51.3 billion to RMB 53.0 billion, a range that places execution and capacity expansion at the center of the next results cycle.

Stock remains below yearly high

WuXi AppTec was last at CNY 162 on the Shanghai Stock Exchange on October 8, 2026, at 3:00 p.m. CST, down 3.19 percent from the prior close of CNY 167.34. The price stood 6.68 percent below the 52-week high of CNY 173.60 and above the 52-week low of CNY 87.09.

Market capitalization was CNY 400.7 billion on October 8, 2026, with volume of 44,716,952 shares. Onvista lists October 27, 2026, for the company's third-quarter report, giving the market a defined checkpoint for testing the raised annual guidance.

WuXi AppTec stock facts

  • Company: WuXi AppTec Co., Ltd.
  • Ticker: 603259
  • Trading venue: Shanghai Stock Exchange
  • Price (as of October 8, 2026, 3:00 p.m. CST): CNY 162
  • Market capitalization: CNY 400.7 billion (as of October 8, 2026)
  • 52-week range: CNY 87.09-173.60 (as of October 8, 2026)
  • Sector / Industry: Healthcare / Medical Diagnostics and Research

Disclaimer...

en | boerse | 70263713 |